Replies to post #65385 on Ayala Pharmaceuticals Inc (ADXS)

[jckrdu]

"If they are in negotiations I don't see the clinical hold as a hold up... do you?"
------------------------------------------

I think the clinical hold could be impacting things, either a buyout or a major deal for AXAL. The partnering company could want to hear definitive news from the FDA on their view of the hold, before executing a major strategic transaction.

Part of Advaxis value is in PD-1 combo therapies. Given that the combo trial with Merck didn't have any issues, I think its unlikely the hold impacts all LM & PD-1 combo trials/plans (beyond the Astra combo trial), but it could. A potential partner may want to have that clarity before pulling the trigger on a major deal.